1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol has been researched along with Akinetic-Rigid Variant of Huntington Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dragunow, M; Glass, M; Goodfellow, CE; Graham, ES; Scotter, EL | 1 |
| Dowie, MJ; Faull, RL; Glass, M; Hannan, AJ; Howard, ML; Nicholson, LF | 1 |
| Armida, M; Beggiato, S; Chiodi, V; Domenici, MR; Ferrante, A; Ferraro, L; Martire, A; Popoli, P; Potenza, RL; Tanganelli, S; Uchigashima, M; Watanabe, M | 1 |
3 other study(ies) available for 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Neuroprotective potential of CB1 receptor agonists in an in vitro model of Huntington's disease.
Topics: Animals; Butadienes; Cell Culture Techniques; Cell Death; Cell Line, Transformed; Cerebellum; Cyclic AMP; Dronabinol; GTP-Binding Protein alpha Subunits; Humans; Huntingtin Protein; Huntington Disease; Mice; Mitogen-Activated Protein Kinase 3; Nerve Tissue Proteins; Neuroprotective Agents; Nitriles; Nuclear Proteins; PC12 Cells; Pertussis Toxin; Piperidines; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Receptors, Dopamine; Rimonabant | 2010 |
Behavioural and molecular consequences of chronic cannabinoid treatment in Huntington's disease transgenic mice.
Topics: Animals; Behavior, Animal; Cannabinoids; Cohort Studies; Corpus Striatum; Disease Models, Animal; Dronabinol; Drug Administration Schedule; Huntington Disease; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Transgenic; Random Allocation; Receptor, Cannabinoid, CB1; Treatment Outcome | 2010 |
Unbalance of CB1 receptors expressed in GABAergic and glutamatergic neurons in a transgenic mouse model of Huntington's disease.
Topics: Action Potentials; Analysis of Variance; Animals; Benzoxazines; Brain; Disease Models, Animal; Dronabinol; Drug Interactions; Electric Stimulation; Excitatory Amino Acid Agents; gamma-Aminobutyric Acid; Glutamates; Humans; Huntingtin Protein; Huntington Disease; In Vitro Techniques; Mice; Mice, Transgenic; Microscopy, Immunoelectron; Morpholines; Motor Activity; Naphthalenes; Nerve Tissue Proteins; Neurons; Nuclear Proteins; Patch-Clamp Techniques; Piperidines; Potassium; Pyrazoles; Receptor, Cannabinoid, CB1; Statistics, Nonparametric; Synaptosomes; Trinucleotide Repeats; Tritium; Vesicular Glutamate Transport Protein 1; Vesicular Inhibitory Amino Acid Transport Proteins | 2012 |